Sangamo BioSciences | SGMO - Ebitda





Ebitda Alterar Data
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.8B 1.25B 2026-09
Bayer EUR 1.62B 529M 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Cipla INR 13.88B 154.2M 2026-09
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -8.84M 180K 2026-06
CSL USD 3.13B 1.17B 2025-12
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Grifols EUR 482.04M 7.04M 2025-09
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
J&J USD 8.99B 721M 2026-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Omeros USD -47.96M 7.39M 2023-09
Pfizer USD 6.36B 350M 2026-09
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Tectonic Therapeutic USD -21.18M 365K 2025-12
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09